Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1101

BIPERIDEN
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2

Basic Information

ChEMBL ID CHEMBL1101
Name BIPERIDEN
Phase Approved
Structure Type MOL
InChI Key YSXKPIUOCJLQIE-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Akineton- Biperiden Biperidene Biperideno Biperidenum KL 373 NSC-759145
5
Targets
5
Activities
1
Assay Types
11
PK Parameters
20
Publications
7
Known Names
6
Indications

Molecular Properties

311.5
MW (Da)
3.96
ALogP
2
HBA
1
HBD
23.5
PSA (Ų)
0.83
QED
0
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1959
Availability Discontinued
Chirality Racemic

Routes of Administration

Oral Parenteral

Extended Properties

Molecular Formula C21H29NO
MW 311.47
Aromatic Rings 1
Heavy Atoms 23
NP-Likeness -0.28

Indications

Parkinson Disease Anxiety Cocaine-Related Disorders Dementia Depressive Disorder Schizophrenia

ATC Classification

N04AA02
biperiden
Level 1: NERVOUS SYSTEM
Level 2: ANTI-PARKINSON DRUGS

Activity Summary

Ki 5 meas. best 8.63

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Muscarinic acetylcholine receptor M1
CHEMBL216
Ki 8.63 8.63 2.4 1
Muscarinic acetylcholine receptor M3
CHEMBL245
Ki 8.22 8.22 6.0 1
Unchecked
CHEMBL612545
Ki 7.98 7.98 10.5 1
Muscarinic acetylcholine receptor M2
CHEMBL211
Ki 7.86 7.86 13.7 1
Muscarinic acetylcholine receptor M4
CHEMBL1821
Ki 7.49 7.49 32.1 1

Pharmacokinetic Data

Parameter Value Units Species
CL 12.0 mL.min-1.kg-1 Homo sapiens
CL 12.0 mL.min-1.kg-1 Homo sapiens
CL 68.0 mL.min-1.kg-1 Rattus norvegicus
CL 12.0 mL.min-1.kg-1 Homo sapiens
CL 15.3 mL.min-1.kg-1 Homo sapiens
CL 21.9 mL.min-1.kg-1 Macaca
CL 27.0 mL.min-1.kg-1 Canis lupus familiaris
Fu 0.097 - Homo sapiens
Fu 0.097 - Homo sapiens
MRT 17.0 hr Homo sapiens
T1/2 24.0 hr Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
31158845 10.1038/s41586-019-1291-3 ADMET 69
- 10.5281/zenodo.13943903 ADMET 60
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
20070106 10.1021/jm901371v Homo sapiens 8
16621936 10.1124/dmd.105.006619 ADMET 8
18426954 10.1124/dmd.108.020479 ADMET 4
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M1 4
37468498 10.1038/s41467-023-40064-9 Nuclear receptor subfamily 1 group I member 2 3
12438524 10.1124/jpet.102.039255 ATP-dependent translocase ABCB1 2
26948801 10.1016/j.drudis.2016.02.015 Homo sapiens 2
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
37468498 10.1038/s41467-023-40064-9 Progesterone receptor 2
37468498 10.1038/s41467-023-40064-9 Peroxisome proliferator-activated receptor gamma 2
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M2 2
23523385 10.1016/j.bmc.2013.01.072 Muscarinic acetylcholine receptor M1 and M3 2
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2A 2
2579237 10.1021/jm00381a019 Sodium channel alpha subunits; brain (Types I, II, III) 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2B 2
37468498 10.1038/s41467-023-40064-9 Cannabinoid receptor 1 2

Data from ChEMBL 36 via Core Engine